Sleep Aids: Technologies and Global Markets
Report Highlights
-
The worldwide sleep aids markets reached revenues of $25 billion in 2009. Revenues are anticipated to reach $33.2 billion in 2014, growing at a compound annual growth rate (CAGR) of 5.8% over the forecast period of 2009 to 2014.
-
The largest market in terms of annual revenues is the mattresses and pillows segment, but it is currently the slowest growing of all the markets. This segment was worth $10.6 billion in 2009 and is expected to reach $12.5 billion by 2015, a compound annual growth rate (CAGR) of 3.3%.
-
The second-largest market is sleep laboratories, with revenues of $6.7 billion in 2009. This segment is expected to grow at a compound annual growth rate (CAGR) of 6.5% to reach $9.2 billion in 2014.
SCOPE OF STUDY
The report is designed to be a comprehensive business tool to provide an in-depth look at therapies for sleep disorders. The geographic scope of the report is global with an emphasis on the United States. The report identifies the different disorders that manifest with sleep disorder symptoms; gives an explanation of the disorders; cites incidence; identifies drugs; presents current device treatments, laboratory testing, market size, and market participants; and presents potential treatments in research and development.
The Sleep Aids: Technologies and Global Markets report is a multifaceted market consisting of many products to aid in the quest for a good night’s rest. These aids include the following:
- Medications
- Prescription
- Over-the-counter (OTC)
- Herbal remedies
- Sleep laboratories
- Sleep apnea devices
- Mattresses and pillows
All markets are further broken down into specific types of products that are discussed in detail, measuring current and potential market size, identifying current and potential market drivers, detailing from 2008, 2009, and 2014, assessing current and potential competitors, and identifying current competitor market shares.
ANALYST CREDENTIALS
Mary Anne Crandall is a medical analyst specializing in the pharmaceutical industry for the last 18 years. She has completed several in-depth studies on various medical topics requiring both great medical expertise and excellent knowledge of the industry. She is a former nurse and university instructor, has an M.S. in psychology and is pursuing a Ph.D.